Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.

Lawler PR, Kotrri G, Koh M, Goodman SG, Farkouh ME, Lee DS, Austin PC, Udell JA, Ko DT.

Eur Heart J. 2019 Nov 16. pii: ehz767. doi: 10.1093/eurheartj/ehz767. [Epub ahead of print]

PMID:
31733058
2.

Population Impact of Generic Valsartan Recall.

Jackevicius CA, Krumholz HM, Chong A, Koh M, Ozaki AF, Austin PC, Udell JA, Ko DT.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044494. [Epub ahead of print]

PMID:
31707798
3.

Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry.

Bagai A, Chen AY, Udell JA, Dodson JA, McManus DD, Maurer MS, Enriquez JR, Hochman J, Goyal A, Henry TD, Gulati M, Garratt KN, Roe MT, Alexander KP.

J Am Heart Assoc. 2019 Sep 3;8(17):e012929. doi: 10.1161/JAHA.119.012929. Epub 2019 Aug 29.

4.

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.

Sparrow RT, Khan AM, Ferreira-Legere LE, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA.

JAMA Cardiol. 2019 Aug 28. doi: 10.1001/jamacardio.2019.3066. [Epub ahead of print]

PMID:
31461127
5.

Socioeconomics and Atherosclerosis: Where There's Smoke, There's Fire.

Udell JA.

J Am Coll Cardiol. 2019 Jul 30;74(4):536-537. doi: 10.1016/j.jacc.2019.06.018. No abstract available.

PMID:
31345428
6.

Improving Statin Noncompliance: If You Build It, Will They Come?

Sparrow RT, Ferreira-Legere L, Udell JA, Waters DD.

Can J Cardiol. 2019 Jul;35(7):813-815. doi: 10.1016/j.cjca.2019.05.011. No abstract available.

7.

Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry.

Fanaroff AC, Vora AN, Chen AY, Mathews R, Udell JA, Roe MT, Thomas LE, Wang TY.

Am Heart J. 2019 Aug;214:184-193. doi: 10.1016/j.ahj.2019.05.011. Epub 2019 May 25.

PMID:
31234037
8.

Exploring medically-related Canadian summer student research programs: a National Cross-sectional Survey Study.

Patel S, Walsh CM, Udell JA.

BMC Med Educ. 2019 May 14;19(1):140. doi: 10.1186/s12909-019-1577-z.

9.

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study.

Kytömaa S, Hegde S, Claggett B, Udell JA, Rosamond W, Temte J, Nichol K, Wright JD, Solomon SD, Vardeny O.

JAMA Cardiol. 2019 Apr 1;4(4):363-369. doi: 10.1001/jamacardio.2019.0549.

PMID:
30916717
10.

Trends in Performance and Opportunities for Improvement on a Composite Measure of Acute Myocardial Infarction Care.

Desai NR, Udell JA, Wang Y, Spatz ES, Dharmarajan K, Ahmad T, Julien HM, Annapureddy A, Goyal A, de Lemos JA, Masoudi FA, Bhatt DL, Minges KE, Krumholz HM, Curtis JP.

Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e004983. doi: 10.1161/CIRCOUTCOMES.118.004983.

PMID:
30871375
11.

Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario.

Donio PJ, Freitas C, Austin PC, Ross HJ, Abdel-Qadir HM, Wijeysundera HC, Tu K, Cram P, Liu P, Abrams H, Udell JA, Mak S, Farkouh ME, Tu JV, Wang X, Tobe SW, Lee DS.

Can J Cardiol. 2019 Mar;35(3):341-351. doi: 10.1016/j.cjca.2019.01.004.

PMID:
30825954
12.

Erratum to "Cardiovascular Protection in People With Diabetes": Canadian Journal of Diabetes 2018;42(S1):S162-S169.

Stone JA, Houlden RL, Lin P, Udell JA, Verma S.

Can J Diabetes. 2019 Mar;43(2):154. doi: 10.1016/j.jcjd.2018.12.004. Epub 2018 Dec 20. No abstract available.

PMID:
30823979
13.

Living alone and cardiovascular disease outcomes.

Gandhi S, Goodman SG, Greenlaw N, Ford I, McSkimming P, Ferrari R, Jang Y, Alcocer-Gamba MA, Fox K, Tardif JC, Tendera M, Dorian P, Steg G, Udell JA.

Heart. 2019 Jul;105(14):1087-1095. doi: 10.1136/heartjnl-2018-313844. Epub 2019 Feb 21.

14.

Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial.

Bergmark BA, Udell JA, Morrow DA, Jarolim P, Kuder JF, Solomon SD, Pfeffer MA, Braunwald E, Sabatine MS.

Eur J Heart Fail. 2019 Apr;21(4):462-470. doi: 10.1002/ejhf.1424. Epub 2019 Feb 18.

PMID:
30773798
15.

The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry.

Dodson JA, Hochman JS, Roe MT, Chen AY, Chaudhry SI, Katz S, Zhong H, Radford MJ, Udell JA, Bagai A, Fonarow GC, Gulati M, Enriquez JR, Garratt KN, Alexander KP.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2287-2296. doi: 10.1016/j.jcin.2018.08.028. Erratum in: JACC Cardiovasc Interv. 2019 Apr 8;12(7):695-696.

PMID:
30466828
16.

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry.

Patel A, Goodman SG, Yan AT, Alexander KP, Wong CL, Cheema AN, Udell JA, Kaul P, D'Souza M, Hyun K, Adams M, Weaver J, Chew DP, Brieger D, Bagai A.

J Am Heart Assoc. 2018 Sep 18;7(18):e009859. doi: 10.1161/JAHA.118.009859.

17.

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.

Hicks BM, Filion KB, Yin H, Sakr L, Udell JA, Azoulay L.

BMJ. 2018 Oct 24;363:k4209. doi: 10.1136/bmj.k4209.

18.

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L.

Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27.

PMID:
30150234
19.

Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).

Worme MD, Tan MK, Armstrong DWJ, Yan AT, Tan NS, Brieger D, Budaj A, Gore JM, López-Sendón J, Van de Werf F, Steg PG, Fox KAA, Goodman SG, Udell JA.

Am J Cardiol. 2018 Sep 15;122(6):944-951. doi: 10.1016/j.amjcard.2018.06.001. Epub 2018 Jun 21.

PMID:
30115426
20.

High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial.

Vardeny O, Udell JA, Joseph J, Farkouh ME, Hernandez AF, McGeer AJ, Talbot HK, Bhatt DL, Cannon CP, Goodman SG, Anand I, DeMets DL, Temte J, Wittes J, Nichol K, Yancy CW, Gaziano JM, Cooper LS, Kim K, Solomon SD.

Am Heart J. 2018 Aug;202:97-103. doi: 10.1016/j.ahj.2018.05.007. Epub 2018 May 23.

21.

Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry.

Udell JA, Desai NR, Li S, Thomas L, de Lemos JA, Wright-Slaughter P, Zhang W, Roe MT, Bhatt DL.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004054. doi: 10.1161/CIRCOUTCOMES.117.004054.

PMID:
29848476
22.

Projected Real-World Effectiveness of Using Aggressive Low-Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada.

Alter DA, Tu JV, Koh M, Jackevicius CA, Austin PC, Rezai MR, Bhatia RS, Johnston S, Udell JA, Ko DT.

J Am Heart Assoc. 2018 May 12;7(10). pii: e007535. doi: 10.1161/JAHA.117.007535.

23.

Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".

Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI.

Circulation. 2018 May 1;137(18):1984-1985. doi: 10.1161/CIRCULATIONAHA.117.033238. No abstract available.

24.

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.

Bergmark BA, Udell JA, Morrow DA, Cannon CP, Steen DL, Jarolim P, Budaj A, Hamm C, Guo J, Im K, Kuder JF, Braunwald E, Sabatine MS, O'Donoghue ML.

JAMA Cardiol. 2018 Jun 1;3(6):473-480. doi: 10.1001/jamacardio.2018.0653.

25.

Cardiovascular Protection in People With Diabetes.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Stone JA, Houlden RL, Lin P, Udell JA, Verma S.

Can J Diabetes. 2018 Apr;42 Suppl 1:S162-S169. doi: 10.1016/j.jcjd.2017.10.024. No abstract available. Erratum in: Can J Diabetes. 2019 Mar;43(2):154.

PMID:
29650091
26.

Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).

Ghosh-Swaby OR, Tan M, Bagai A, Yan AT, Goodman SG, Mehta SR, Fisher HN, Cohen EA, Huynh T, Cantor WJ, Le May MR, Déry JP, Welsh RC, Udell JA.

Clin Cardiol. 2018 Mar;41(3):285-292. doi: 10.1002/clc.22901. Epub 2018 Mar 25.

27.

Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.

Udell JA, Fonarow GC, Maddox TM, Cannon CP, Frank Peacock W, Laskey WK, Grau-Sepulveda MV, Smith EE, Hernandez AF, Peterson ED, Bhatt DL; Get With The Guidelines Steering Committee and Investigators.

Clin Cardiol. 2018 Jun;41(6):758-768. doi: 10.1002/clc.22938. Epub 2018 May 11.

28.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel.

Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19. Review.

PMID:
29475527
29.

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, Im K, Kanevsky E, Stahre C, Sjöstrand M, Raz I, Braunwald E.

JAMA Cardiol. 2018 Feb 1;3(2):155-163. doi: 10.1001/jamacardio.2017.4228.

30.

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest.

Sarak B, Goodman SG, Brieger D, Gale CP, Tan NS, Budaj A, Wong GC, Huynh T, Tan MK, Udell JA, Bagai A, Fox KAA, Yan AT; Global Registry of Acute Coronary Events (GRACE) Investigators and the Canadian Acute Coronary Syndromes I Investigators.

Am J Cardiol. 2018 Feb 1;121(3):294-300. doi: 10.1016/j.amjcard.2017.10.030. Epub 2017 Nov 3.

PMID:
29197473
31.
32.

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI.

Circulation. 2017 Oct 24;136(17):1643-1658. doi: 10.1161/CIRCULATIONAHA.117.030012. Review.

33.

Preoperative Intraaortic Balloon Pump Improves Early Outcomes Following High-Risk Coronary Artery Bypass Graft Surgery: A Meta-Analysis of Randomized Trials and Prospective Study Design.

Rampersad PP, Udell JA, Zawi R, Ouzounian M, Overgaard CB, Sharma V, Rao V, Farkouh ME, Džavík V.

J Invasive Cardiol. 2018 Jan;30(1):2-9. Epub 2017 Sep 15.

34.

Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis.

Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T, Basso O, Udell JA.

J Am Coll Cardiol. 2017 Sep 5;70(10):1203-1213. doi: 10.1016/j.jacc.2017.07.753. Review.

35.

Improving the Appropriate Use of Transthoracic Echocardiography: The Echo WISELY Trial.

Bhatia RS, Ivers NM, Yin XC, Myers D, Nesbitt GC, Edwards J, Yared K, Wadhera RK, Wu JC, Kithcart AP, Wong BM, Hansen MS, Weinerman AS, Shadowitz S, Elman D, Farkouh ME, Thavendiranathan P, Udell JA, Johri AM, Chow CM, Hall J, Bouck Z, Cohen A, Thorpe KE, Rakowski H, Picard MH, Weiner RB.

J Am Coll Cardiol. 2017 Aug 29;70(9):1135-1144. doi: 10.1016/j.jacc.2017.06.065.

36.

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

Gong IY, Goodman SG, Brieger D, Gale CP, Chew DP, Welsh RC, Huynh T, DeYoung JP, Baer C, Gyenes GT, Udell JA, Fox KAA, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators.

Int J Cardiol. 2017 Oct 1;244:24-29. doi: 10.1016/j.ijcard.2017.06.055. Epub 2017 Jun 15.

37.

Regional variations in ambulatory care and incidence of cardiovascular events.

Tu JV, Chu A, Maclagan L, Austin PC, Johnston S, Ko DT, Cheung I, Atzema CL, Booth GL, Bhatia RS, Lee DS, Jackevicius CA, Kapral MK, Tu K, Wijeysundera HC, Alter DA, Udell JA, Manuel DG, Mondal P, Hogg W; Cardiovascular Health in Ambulatory Care Research Team (CANHEART).

CMAJ. 2017 Apr 3;189(13):E494-E501. doi: 10.1503/cmaj.160823.

38.

Failure of fertility therapy and subsequent adverse cardiovascular events.

Udell JA, Lu H, Redelmeier DA.

CMAJ. 2017 Mar 13;189(10):E391-E397. doi: 10.1503/cmaj.160744.

39.

The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors.

Secrest MH, Udell JA, Filion KB.

Trends Cardiovasc Med. 2017 Apr;27(3):194-202. doi: 10.1016/j.tcm.2017.01.009. Epub 2017 Jan 28. Review.

PMID:
28291655
40.
41.

Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization.

Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A, Yan AT, Goodman SG, Tu JV, Ko DT.

J Am Heart Assoc. 2017 Jan 20;6(1). pii: e004319. doi: 10.1161/JAHA.116.004319.

42.

Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists: With Great Power Comes Great Responsibility.

Cherney DZ, Udell JA.

Circulation. 2016 Dec 13;134(24):1915-1917. No abstract available. Erratum in: Circulation. 2017 Feb 14;135(7):e49.

PMID:
27956401
43.

Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review.

Alabousi M, Abdullah P, Alter DA, Booth GL, Hogg W, Ko DT, Manuel DG, Farkouh ME, Tu JV, Udell JA.

Can J Cardiol. 2017 Mar;33(3):393-404. doi: 10.1016/j.cjca.2016.07.005. Epub 2016 Jul 18. Review.

PMID:
27876171
44.

Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.

Goldenberg GR, Burd D, Lodzinski P, Stabile G, Udell JA, Newman D, Shurrab M, Crystal E.

J Interv Card Electrophysiol. 2016 Nov;47(2):171-176. Epub 2016 Jun 29. Review.

PMID:
27357216
45.

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.

Scirica BM, Bhatt DL, Braunwald E, Raz I, Cavender MA, Im K, Mosenzon O, Udell JA, Hirshberg B, Pollack PS, Steg PG, Jarolim P, Morrow DA.

JAMA Cardiol. 2016 Dec 1;1(9):989-998. doi: 10.1001/jamacardio.2016.3030.

PMID:
27681000
46.

Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.

Fitchett DH, Udell JA, Inzucchi SE.

Eur J Heart Fail. 2017 Jan;19(1):43-53. doi: 10.1002/ejhf.633. Epub 2016 Sep 21. Review.

48.

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.

Bagai A, Bhatt DL, Eikelboom JW, Mancini GB, Cohen EA, Vijayaraghavan R, Cheema AN, Udell JA, Niznick J, Tanguay JF, Verma S, Mehta SR.

Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158. Review. No abstract available.

PMID:
27217435
49.

Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndrome.

Sarak B, Goodman SG, Yan RT, Tan MK, Steg PG, Tan NS, Fox KA, Udell JA, Brieger D, Welsh RC, Gale CP, Yan AT; Canadian Acute Coronary Syndromes I, and Global Registry of Acute Coronary Events (GRACE) Investigators.

Heart. 2016 Sep 1;102(17):1396-402. doi: 10.1136/heartjnl-2015-309161. Epub 2016 Apr 25.

PMID:
27112175
50.

No Need to Sugarcoat the Message: Is Cardiovascular Risk Reduction From SGLT2 Inhibition Related to Natriuresis?

Perkins BA, Udell JA, Cherney DZ.

Am J Kidney Dis. 2016 Sep;68(3):349-52. doi: 10.1053/j.ajkd.2016.03.410. Epub 2016 Mar 30. No abstract available.

PMID:
27039253

Supplemental Content

Loading ...
Support Center